Real-time enrollment status for this rare genitourinary tumors clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 1:35 AM UTC
| NCT Number | NCT03866382 |
| Recruiting Status | Recruiting |
| Condition | Rare Genitourinary Tumors |
| Phase | PHASE2 |
| Target Enrollment | 314 participants |
| Active Locations | 581 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | July 9, 2026 (1 week ago) |
As of July 17, 2026: Clinical trial NCT03866382 is currently recruiting participants. This phase2 study for rare genitourinary tumors is actively seeking new participants at 581 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03866382 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 581 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03866382 was last updated 1 week ago (July 9, 2026). HelloStudys verifies this status automatically.